Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01966081
Other study ID # Bonithon hors AOI 2008
Secondary ID
Status Recruiting
Phase N/A
First received October 10, 2013
Last updated October 16, 2013

Study information

Verified date October 2013
Source Centre Hospitalier Universitaire Dijon
Contact Claire BONITHON-KOPP
Phone 3 80 39 33 37
Email bonithon@u-bourgogne.fr
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The aim of the study is to establish the existence of a relationship between the dietary intake of polyunsaturated fatty acids (PUFA) and the risk of colorectal cancer in humans, using 2 reliable and complementary biomarkers: the fatty acid-composition of lipids of the abdominal subcutaneous adipose tissue and the fatty acid composition of erythrocyte phospholipids.


Recruitment information / eligibility

Status Recruiting
Enrollment 576
Est. completion date
Est. primary completion date November 2014
Accepts healthy volunteers
Gender Both
Age group 45 Years and older
Eligibility Inclusion Criteria:

CASES

- Patients aged = 45 years

- with a first recently-diagnosed colorectal cancer

- due to undergo elective surgical resection with curative intent (in practice, stage I, II, III or IV if there was only one hepatic nodule that was resected with curative intent) in one of the 5 following digestive surgery units: CHU de Dijon, CHU de Nancy, CHU de Strasbourg, CHU de Reims et CHU and Besançon.

- who have given their informed consent

CONTROLS

- Patients aged = 45 years

- due to undergo surgery for a benign abdominal disease (sigmoid diverticulitis, appendectomy, hiatal hernia …)

- matched for abdominal site with cases for age (± 3 years), sex and hospital

- Who have given their informed consent

Exclusion Criteria:

CASES

- pre-operative anticancer treatment (chemo or radiotherapy)

- existence of visceral metastases except a single hepatic nodule resected with curative intent

- familial adenomatous polyposis and HNPCC syndrome (when suspected: inclusion after complementary tumor phenotype study: screening for microsatellite instability and/or immunohistochemistry study of the expression of DNA mismatch repair proteins.

- known inflammatory disease of the intestine (ulcerative colitis, Crohn's disease)

- personal history (recent or not) of colorectal cancer

- emergency treatment for the presenting complication (perforation, occlusion…)

- significant modification in dietary habits during the previous three months

- other evolving neoplastic disease

- psychic state incompatible with understanding the modalities and the aims of the study (notably patients under guardianship)

- pregnant or breast-feeding women

CONTROLS

- personal history of cancer or adenomatous colorectal polyps,

- emergency intervention

- known inflammatory disease of the intestine (ulcerative colitis, Crohn's disease)

- personal history (recent or not) of colorectal cancer

- emergency treatment for the presenting complication (perforation, occlusion…)

- significant modification in dietary habits during the previous three months

- evolving neoplastic disease

- psychic state incompatible with understanding the modalities and the aims of the study (notably patients under guardianship)

- pregnant or breast-feeding women

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Other:
Blood sample

tissue samples from abdominal subcutaneous adipose


Locations

Country Name City State
France CHU Jean Minjoz Besancon
France CHU Dijon Dijon
France Hôpital Robert Debré Reims
France Hôpital Hautepierre Strasbourg
France Hôpital de BRABOIS Vandoeuvre-les-nancy

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure of polyunsaturated fatty acids in adipose tissue lipids. baselines No